The size of the Radiotherapy Market in North America was worth USD 2.13 billion in 2022 and is estimated to be growing at a CAGR of 5.54% to reach USD 2.79 billion by 2027.
North America is the utmost vibrant, extremely competitive, and the leading market for radiotherapy devices globally. The market growth is considerably higher in North America since it is continuously inclined to use novel technologies. Radiation therapy practices high-energy radiation on directed cells and cell progression to stop them from growing and distributing. Emissions are mainly from an external machine or implants, i.e., an internal mechanism placed near the tumors. This technique is widely used to treat cancerous tumors, benign tumors, and other conditions like thyroid disease and some blood disorders.
The North American Radiotherapy Market is driven by quickly altering cancer treatment technology and increasing cancer patients. Technological advancements also drive biological and molecular imaging techniques that permit radiotherapy to be progressively personalized for patient needs. Emerging healthy reimbursement plans and untapped markets in few areas are also a few factors fuelling the radiotherapy market's growth.
However, growing healthcare expenditure and alternative treatment procedures are estimated to hamper the growth rate of the North American radiotherapy market.
This research report on the North American Radiotherapy market has been segmented and sub-segmented into the following categories:
By Equipment Type:
KEY MARKET PLAYERS:
Companies playing a promising role in the North America radiotherapy market profiled in this report are Nordion Inc., RaySearch Laboratories AB, Ion Beam Applications SA, C. R. Bard Inc., Mevion Medical Systems Inc., Varian Medical Systems Inc., IsoRay Medical Inc., Elekta AB, Accuray Incorporated and Mitsubishi Electric Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org